Back

The underestimated risk of prediabetes on cardiovascular and renal outcomes in patients with heart failure

30 August 2025 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Cardiometabolic diseases (2) Diabetes and the Heart ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Andreas Hammer

Medical University of Vienna, Vienna (Austria)

5 More presentations in this session

Presentation thumbnail
Microvascular endothelial function predicts incident diabetes mellitus: the ELSA-Brasil cohort study
Doctor L. Brant (Belo Horizonte, BR)
Abstract Slides Video
Presentation thumbnail
The Relationship Between High-Sensitivity CRP and Cardiac Function in Patients with Type 2 Diabetes: A Cardiac Magnetic Resonance Study
Doctor A. Bojer (Gentofte, DK)
Abstract Slides Video
Presentation thumbnail
AI-enabled opportunistic measurement of liver steatosis in coronary artery calcium scans predicts cardiovascular events and mortality: an AI-CVD study
Doctor M. Naghavi (Houston, US)
Abstract Slides Video
Presentation thumbnail
Inflammatory biomarkers suPAR, IL-6, and hsCRP and 13-year risk of mortality and MACE in type 2 diabetes: a prospective cohort study
Doctor H. Bahrami (Herlev, DK)
Abstract Slides Video
Presentation thumbnail
Time for cardiologists to focus on prediabetes: challenges in risk factor control
Assistant Professor V. Medovchshikov (Aktobe, KZ)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiometabolic diseases (2)

The Event

Event poster

ESC Congress 2025

30 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Presentation
The underestimated risk of prediabetes on cardiovascular outcomes in heart failure with reduced left ventricular function
thumbnail
Congress Presentation
Impact of diabetes mellitus on clinical characteristics, treatment patterns, and outcomes in heart failure patients: a retrospective multi-center, multi-ethnic cohort study
thumbnail
Congress Presentation
Cardiovascular diseases and type 2 diabetes mellitus: high heart failure risk and low rate contraindications to SGLT2i

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources